A spectrum of nonsense-mediated mRNA decay efficiency along the degree of mutational constraint
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; none of the 16 sources its claims cite is checked for support yet.
Abstract
Despite its importance for regulating gene expression, nonsense-mediated mRNA decay (NMD) remains poorly understood. Here, we extend the findings of a previous landmark study that proposed several factors associated with NMD efficiency using matched genome and transcriptome data from The Cancer Genome Atlas Program (TCGA) by incorporating additional data including Genotype-Tissue Expression (GTEx), gnomAD, and metrics for mutational constraints. Factors affecting NMD efficiency are analyzed using an allele-specific expression (ASE)-based measure to reduce noise caused by random variations. Additionally, by combining our data with the updated allele frequency database of gnomAD, we demonstrate the spectrum of NMD efficiency according to the degree of gene-level mutational constraints (degree of a gene-tolerating loss-of-function variants). The NMD prediction model, trained on TCGA data, shows that gene-level mutational constraint is an important predictor of NMD efficiency. Findings of this study suggest the potential role of NMD on shaping the landscape of mutational constraints.
Overview
CoChat Summary
TL;DR
This study uses matched genome/transcriptome data from TCGA and GTEx plus gnomAD mutational-constraint metrics to model nonsense-mediated mRNA decay (NMD) efficiency with an allele-specific expression (ASE)-based measure. It reports a spectrum of NMD efficiency along gene-level mutational constraint (LOEUF), with gene-level constraint emerging as a predictor in a TCGA-trained random forest model.
Key findings
- In TCGA, 4,257 nonsense variants from 9,235 samples across 32 tumor types showed wide NMD-efficiency variability among predicted NMD-sensitive variants and concentration near zero among predicted NMD-escaping variants; adding start-proximal and long-exon rules gave only marginal discriminative benefit over the two canonical rules.
- NMD efficiency increased with greater mutational constraint (lower LOEUF) in TCGA variants, most evident across LOEUF deciles; this trend was not evident in GTEx, which the authors attribute to depletion of high-NMD-efficiency, low-LOEUF germline variants.
- The final random forest model used 14 features and explained 43.7% of total variance; against a non-random variance of 46%, this corresponded to 95% (43.7/46.0) of explainable variance. LOEUF ranked eighth in feature importance, and adding cancer type did not improve performance (R² 43.7% to 43.1%).
- ASE-based models had significantly higher explainable variance than TPM-based models across all parameter combinations; predicted NMD efficiency was higher than observed in all AF subsets of GTEx, suggesting depletion of high-NMD-efficiency variants in the general population.
Methods
- TCGA: downloaded WES, copy-number, and expression data from GDC for 9,235 tumor samples/32 tumor types; extracted nonsense variants in copy-neutral genes (CN=2), excluded variants with <5 reads and matched-normal VAF >0 and <0.3, and excluded genes with >2 NMD-triggering variants; initial 50,591 nonsense variants; final 4,257 after tumor VAF ≥0.3, tumor DOC ≥30, RNA DOC ≥30, and collapsing. RNA-seq variant calling used Mutect2/hg38; NMD efficiency = −log2(VAFRNA/VAFDNA).
- GTEx: from ASE data of 844 individuals (V8), extracted 131,584 nonsense variants, used WASP-filtered ASE tables, excluded RNA DOC <30, collapsed repeated tissue samples, and calculated NMD efficiency as −log2(VAFRNA/0.5); final dataset 18,055 variants from 54 tissue types. De novo DB: 415,516 variants, 1,817 nonsense, final 864. MMRF/TARGET validation followed the same procedures but lacked copy-number information.
- Modeling/statistics: random forest regression with 10,000 trees, max three features, 5-fold cross-validation, 14 features, target NMD efficiency; TCGA split into training n=3,301 and test n=826. Wilcoxon signed-rank, Pearson/Spearman, and Shapiro-Wilk tests were performed in R 4.2.2.
Limitations
- The paper states: the ASE-based VAF measure is an indirect estimate still subject to random variance; future work should use higher-DOC data or direct measures such as single-molecule imaging. It also states frameshift variants were excluded due to mapping bias; WASP filtering was used for GTEx but not TCGA/MMRF-TARGET, though the authors assume mapping-bias inaccuracy was minor.
- The paper states: in MMRF-TARGET validation, predicted NMD efficiencies were considerably higher than observed despite correlation; the authors assume this was due to high expression of truncated transcripts in amplified genetic regions because copy-number information was unavailable. It also states somatic variants may not be free from selective pressure because driver mutations can be under selection, though they assume the effect was minor.
- Evident from the text: GTEx analyses are limited by depletion of low-LOEUF variants, and the AF[0] GTEx subset is younger with lesser negative-selection effect; de novo variants lacked RNA-seq, so observed NMD efficiency could not be derived. Some start-proximal trend analyses used limited samples (n=419 and 517 for Supplementary Fig. 9B/C).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4 Observed (from RNAseq) and predicted (by the RFR model trained in this study) NMD efficiency. A Observed and predicted NMD efficiencies of AF-stratified subsets of GTEx variants, TCGA variants, MMRF-TARGET variants, and de novo variants (observed NMD efficiency from de novo DB was unavailable due to a lack of RNAseq data) are presented. For this experiment, TCGA data were randomly separated into a training set (n = 3301) and a test set (n = 826). B Correlation between observed and predicted NMD efficiency in the AF [0.01, ∞) subset of GTEx. C Correlation between observed and predicted NMD efficiency in the AF [0] subset of GTEx. D Correlation between observed and predicted NMD efficiency in MMRF-TARGET data. Pearson’s test was performed.](https://figures.cochat.ai/paper-figures/dfdb343e69c54322915ae59eeb407fc2/a-spectrum-of-nonsense-mediated-mrna-decay-efficiency-along-the-degree-of-figure-4.jpg)

Verification
Claims the paper makes
0 Valid · 2 Not valid · 10 Not checked · 76 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The depletion of low-LOEUF GTEx variants is evident from the number of variants presented in Fig. 3D.”
§ A spectrum of nonsense-mediated mRNA decay efficiency along the degree of mutational constraint > Results > A spectrum of NMD efficiencies along the gene-level mutational constraint
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In short, the performance of NMD rules for predicting NMD efficiency was the highest for somatic variants, and this was followed by rare germline variants and common germline variants.”
§ A spectrum of nonsense-mediated mRNA decay efficiency along the degree of mutational constraint > Results > The spectrum of NMD efficiency and the capability of NMD rules for predicting NMD efficiency in somatic variants, rare germline variants, and common germline variants
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, in this subset, the NMD efficiency distributions of predicted NMD-escaping variants and predicted NMD-sensitive variants exhibited an almost complete overlap by all four rules (the “last exon,” “last 50nt of the penultimate exon,” “start proximal,” and “long exon” rules), indicating zero discriminative power of the NMD rules.”
§ A spectrum of nonsense-mediated mRNA decay efficiency along the degree of mutational constraint > Results > The spectrum of NMD efficiency and the capability of NMD rules for predicting NMD efficiency in somatic variants, rare germline variants, and common germline variants
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the importance of the last exon was relatively low”
§ A spectrum of nonsense-mediated mRNA decay efficiency along the degree of mutational constraint > Results > ASE-based model explaining the greater portion of the total variance of NMD efficiency compared to that of the TPM-based model
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, the degree of correlation was not enhanced by filtering variants from smaller genes (Supplementary Data 4).”
§ A spectrum of nonsense-mediated mRNA decay efficiency along the degree of mutational constraint > Results > A spectrum of NMD efficiencies along the gene-level mutational constraint
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
48 more claims
Create a free account to see all 88 claims and to verify the 16 references still open.
- It may state two separate claims as one. 14
- The quote only partly states this claim. 1
- Probably not a substantial claim. 24
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ A spectrum of nonsense-mediated mRNA decay efficiency along the degree of mutational constraint > Results > ASE-based model explaining the greater portion of the total variance of NMD efficiency compared to that of the TPM-based model
“| Last 50 nt penultimate exon | 1 if the PTC is located on the last exon; 0 otherwise | Categorical | −0.174 | p < 0.001 | 0.020 |”
§ A spectrum of nonsense-mediated mRNA decay efficiency along the degree of mutational constraint > Introduction
“PTCs in the last exon of a gene or in the last 50 nt of the penultimate exon are not expected to trigger NMD.”
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2020) · Nature · doi:10.1038/s41586-020-2308-7 · Cited by 9,434
The UCSC Table Browser data retrieval tool
Karolchik, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh103 · Cited by 2,316
Transcriptome and genome sequencing uncovers functional variation in humans
The Geuvadis Consortium, Lappalainen, T., Sammeth, M., Friedländer, M. R., ‘t Hoen, P. A. C., Monlong, J., Rivas, M. A., Gonzàlez-Porta, M., Kurbatova, N., Griebel, T., et al. (2013) · Nature · doi:10.1038/nature12531 · Cited by 1,888
A genomic mutational constraint map using variation in 76,156 human genomes
Chen, S., Francioli, L. C., Goodrich, J. K., Collins, R. L., Kanai, M., Wang, Q., Alföldi, J., Watts, N. A., Vittal, C., Gauthier, L. D., et al. (2024) · Nature · doi:10.1038/s41586-023-06045-0 · Cited by 1,727
A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes
MacArthur, D. G., Balasubramanian, S., Frankish, A., Huang, N., Morris, J., Walter, K., Jostins, L., Habegger, L., Pickrell, J. K., Montgomery, S. B., et al. (2012) · Science · doi:10.1126/science.1215040 · Cited by 1,272
Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes
Lykke-Andersen, S., & Jensen, T. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4063 · Cited by 855
Le Hir, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4987 · Cited by 844
Accumulation of driver and passenger mutations during tumor progression
Bozic, I., Antal, T., Ohtsuki, H., Carter, H., Kim, D., Chen, S., Karchin, R., Kinzler, K. W., Vogelstein, B., & Nowak, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010978107 · Cited by 795
WASP: allele-specific software for robust molecular quantitative trait locus discovery
van de Geijn, B., McVicker, G., Gilad, Y., & Pritchard, J. K. (2015) · Nature Methods · doi:10.1038/nmeth.3582 · Cited by 575
mRNA structure regulates protein expression through changes in functional half-life
Mauger, D. M., Cabral, B. J., Presnyak, V., Su, S. V., Reid, D. W., Goodman, B., Link, K., Khatwani, N., Reynders, J., Moore, M. J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908052116 · Cited by 555
The rules and impact of nonsense-mediated mRNA decay in human cancers
Lindeboom, R. G. H., Supek, F., & Lehner, B. (2016) · Nature Genetics · doi:10.1038/ng.3664 · Cited by 545
Albertson, D. G. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.06.007 · Cited by 527
Binary specification of nonsense codons by splicing and cytoplasmic translation
Thermann, R., Neu‐Yilik, G., Deters, A., Frede, U., Wehr, K., Hagemeier, C., Hentze, M. W., & Kulozik, A. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3484 · Cited by 406
Organizing Principles of Mammalian Nonsense-Mediated mRNA Decay
Popp, M. W.-L., & Maquat, L. E. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-111212-133424 · Cited by 372
The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy
Lindeboom, R. G. H., Vermeulen, M., Lehner, B., & Supek, F. (2019) · Nature Genetics · doi:10.1038/s41588-019-0517-5 · Cited by 327
Effect of predicted protein-truncating genetic variants on the human transcriptome
Rivas, M. A., Pirinen, M., Conrad, D. F., Lek, M., Tsang, E. K., Karczewski, K. J., Maller, J. B., Kukurba, K. R., DeLuca, D. S., Fromer, M., et al. (2015) · Science · doi:10.1126/science.1261877 · Cited by 313
Zhang, J., Sun, X., Qian, Y., LaDuca, J. P., & Maquat, L. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5272 · Cited by 295
To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases
Supek, F., Lehner, B., & Lindeboom, R. G. H. (2021) · Trends in Genetics · doi:10.1016/j.tig.2020.11.002 · Cited by 244
Conserved principles of mammalian transcriptional regulation revealed by RNA half-life
Friedel, C. C., Dölken, L., Ruzsics, Z., Koszinowski, U. H., & Zimmer, R. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp542 · Cited by 230
Nonsense-Mediated mRNA Decay Begins Where Translation Ends
Karousis, E. D., & Mühlemann, O. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032862 · Cited by 213
Mendell, J. T., Medghalchi, S. M., Lake, R. G., Noensie, E. N., & Dietz, H. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8944-8957.2000 · Cited by 172
Single-Molecule Imaging Uncovers Rules Governing Nonsense-Mediated mRNA Decay
Hoek, T. A., Khuperkar, D., Lindeboom, R. G. H., Sonneveld, S., Verhagen, B. M. P., Boersma, S., Vermeulen, M., & Tanenbaum, M. E. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.008 · Cited by 168
Nonsense-mediated RNA decay: an emerging modulator of malignancy
Tan, K., Stupack, D. G., & Wilkinson, M. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00481-2 · Cited by 166
Silva, A. L., Ribeiro, P., Inácio, Â., Liebhaber, S. A., & Romão, L. (2008) · RNA · doi:10.1261/rna.815108 · Cited by 162
Nonsense-Mediated RNA Decay Regulation by Cellular Stress: Implications for Tumorigenesis
Gardner, L. B. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0502 · Cited by 155
A vast resource of allelic expression data spanning human tissues
Castel, S. E., Aguet, F., Mohammadi, P., Aguet, F., Anand, S. K., Ardlie, K., Gabriel, S., Getz, G. A., Graubert, A., Hadley, K., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02122-z · Cited by 143
Bateman, J. F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.3.217 · Cited by 141
Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues
Zetoune, A. B., Fontanière, S., Magnin, D., Anczuków, O., Buisson, M., Zhang, C. X., & Mazoyer, S. (2008) · BMC Genetics · doi:10.1186/1471-2156-9-83 · Cited by 141
Dyle, M. C., Kolakada, D., Cortazar, M. A., & Jagannathan, S. (2020) · WIREs RNA · doi:10.1002/wrna.1560 · Cited by 132
Regulation of nonsense‐mediated mRNA decay
Huang, L., & Wilkinson, M. F. (2012) · WIREs RNA · doi:10.1002/wrna.1137 · Cited by 123
Antisense oligonucleotide–directed inhibition of nonsense-mediated mRNA decay
Nomakuchi, T. T., Rigo, F., Aznarez, I., & Krainer, A. R. (2016) · Nature Biotechnology · doi:10.1038/nbt.3427 · Cited by 110
Karam, R., Carvalho, J., Bruno, I., Graziadio, C., Senz, J., Huntsman, D. D., Carneiro, F., Seruca, R., Wilkinson, M., & Oliveíra, C. (2008) · Oncogene · doi:10.1038/onc.2008.62 · Cited by 107
Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability
Bokhari, A., Jonchère, V., Lagrange, A., Bertrand, R., Svrcek, M., Marisa, L., Buhard, O., Greene, M., Demidova, A., Jia, J., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0079-x · Cited by 89
Assessing allele-specific expression across multiple tissues from RNA-seq read data
Pirinen, M., Lappalainen, T., Zaitlen, N. A., GTEx Consortium, Dermitzakis, E. T., Donnelly, P., McCarthy, M. I., & Rivas, M. A. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv074 · Cited by 83
Bayesian estimation of gene constraint from an evolutionary model with gene features
Zeng, T., Spence, J. P., Mostafavi, H., & Pritchard, J. K. (2024) · Nature Genetics · doi:10.1038/s41588-024-01820-9 · Cited by 81
Loss of RNA expression and allele-specific expression associated with congenital heart disease
McKean, D. M., Homsy, J. G., Wakimoto, H., Patel, N., Gorham, J., DePalma, S. R., Ware, J. S., Zaidi, S., Ma, W., Patel, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms12824 · Cited by 69
Huang, L., Low, A., Damle, S. S., Keenan, M. M., Kuntz, S., Murray, S. F., Monia, B. P., & Guo, S. (2018) · Genome Biology · doi:10.1186/s13059-017-1386-9 · Cited by 56
Nonsense-mediated decay is highly stable across individuals and tissues
Teran, N. A., Nachun, D. C., Eulalio, T., Ferraro, N. M., Smail, C., Rivas, M. A., & Montgomery, S. B. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.06.008 · Cited by 44
Allelic imbalance of somatic mutations in cancer genomes and transcriptomes
Rhee, J.-K., Lee, S., Park, W.-Y., Kim, Y.-H., & Kim, T.-M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01966-z · Cited by 39
Self-citationUsuki, F., Yamashita, A., Shiraishi, T., Shiga, A., Onodera, O., Higuchi, I., & Ohno, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300654110 · Cited by 38
Tournier, I., Raux, G., Fiore, F. D., Maréchal, I., Leclerc, C., Martin, C., Wang, Q., Buisine, M., Stoppa‐Lyonnet, D., Olschwang, S., et al. (2004) · Human Mutation · doi:10.1002/humu.20008 · Cited by 33
Triple Effect of Nonsense-Mediated mRNA Decay Inhibition as a Therapeutic Approach for Cancer
Lejeune, F. (2016) · Single Cell Biology · doi:10.4172/2168-9431.1000136 · Cited by 16
Research works printed but not linked: 1
- Kang, H. & Kim, Y.-G. NMDeff v1.0 10.1016/j.tig.2020.11.002 (2024). · DOI · Paper page
Cited by
Variable efficiency of nonsense-mediated mRNA decay across human tissues, tumors and individuals
Palou-Márquez, G., & Supek, F. (2025) · Genome biology · doi:10.1186/s13059-025-03727-y · Cited by 28
Nonsense-mediated mRNA decay: a key regulatory system engaged in cancer
Pan, H., Wu, X., Hu, B., Xiong, H., Luo, Y., & Zhou, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02503-6 · Cited by 10
Molecular Determinants and Therapeutic Targeting of Stop Codon Readthrough in Eukaryotic Translation
Teodorowicz, W., & Mühlemann, O. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169765 · Cited by 7
Genetic Variants and Disease Mechanisms: Lessons from Monogenic Childhood Epilepsies
Oberlack, A., & Wagner, M. (2025) · Neuropediatrics · doi:10.1055/a-2731-5130 · Cited by 6
Uncovering the isoform-resolution kinetic landscape of nonsense-mediated mRNA decay with EZbakR
Mabin, J. W., Vock, I. W., Machyna, M., Haque, N., Thakran, P., Zhang, A., Rai, G., Leibler, I. N.-M., Inglese, J., Simon, M. D., et al. (2026) · Genome biology · doi:10.1186/s13059-026-04204-w · Cited by 6
Metadata
- Authors
- Kim, Y.-G., Kang, H., Lee, B., Jang, H.-J., Park, J.-H., Ha, C., Park, H., & Kim, J.-W.
- Affiliations
- Samsung Medical Center (KR)
- Sungkyunkwan University (KR)
- Korea Advanced Institute of Science and Technology (KR)
- Samsung (South Korea) (KR)
- Corresponding author
- Park, Jong-ho
- Park, Hogun
- Kim, Jong-Won
- ORCID
- Venue
- Communications Biology
- Published
- 2024-11-07
- Volume
- 7
- Issue
- 1
- Pages
- 1461-1461
- ISSN
- 2399-3642 (ISSN-L)
- PMC
- PMC11544006
- OpenAlex
- W4404130307
- Cited by
- 24
- References
- 45
- Citations by year
- 2026: 17 · 2025: 7
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Communications Biology (publishedVersion, cc-by-nc-nd)
- Research Square (submittedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- Sungkyunkwan University (2019-0-00421)
- National Research Foundation of Korea (No.1711180477, 2022R1A2C2091571)
- Ministry of Science and ICT, South Korea (2019-0-00421)
- Institute for Information and Communications Technology Promotion (2019‐0‐00421)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- nonsense-mediated mRNA decay, mutational constraint, loss-of-function mutations, allele-specific expression, gene expression regulation, TCGA, GTEx
- MeSH terms
- Alleles, Gene Frequency, Humans, Mutation, Neoplasms, RNA, Messenger, Codon, Nonsense, Nonsense Mediated mRNA Decay, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.